iShares Nasdaq Biotechnology ETF (IBB)

Delayed Data
As of Sep 17
 +0.05 / +0.05%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

No recent news for iShares Nasdaq Biotechnology ETF.


1 month+0.19% 3 years+2.88%
3 months-0.80% 5 years+3.12%
1 year-9.33% Since inception+6.53%
Data through 09/18/2019

Quote Details

Previous close$105.14
Open day’s range104.41 – 105.48
Net asset value (NAV)105.25 (09/17/2019)
Daily volume1,285,982
Average volume (3 months)2,331,059
Data as of 4:00pm ET, 09/17/2019

Peer Comparisonvs. Health ETFs

Performance 5-yr return+3.12%+9.15%
Expense Gross exp ratio0.47%1.24%
Risk 5 year sharpe ratio0.180.46
Net assets$6.8B$3.0B
Average market cap$14.3B$35.5B
Average P/E16.623.4
Dividend / Share--0.26%


FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...
IHI iShares U.S. Medical Devices ETF


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AMGN Amgen9.80%
CELG Celgene8.08%
GILD Gilead Sciences7.99%
VRTX Vertex Pharmaceuticals Inc6.26%
ILMN Illumina Inc5.61%
BIIB Biogen3.92%
REGN Regeneron Pharmaceuticals3.76%
ALXN Alexion Pharmaceuticals Inc3.21%
INCY Incyte Corp2.49%
BMRN Biomarin Pharmaceutical Inc1.91%